Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Blocking certain proteins on immune cells may help treat alopecia areata.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Social media can help compare the effectiveness and safety of new arthritis medications.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Nestin helps identify certain melanoma cells in nodular melanoma.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Mesalazine may help treat extensive alopecia areata effectively.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Efalizumab can cause unexpected excessive hair growth.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

DHEA inhibits growth in both mouse and human melanoma cells but works differently in each.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Human bone marrow stem cells increased skin tissue growth in diabetic rats with burns, but not significantly.

TNF-alpha inhibitors can cause various immune-related skin issues.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Oral and topical tranexamic acid effectively and safely improve melasma.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.